Reports of Radiotherapy and Oncology

Published by: Kowsar

Olfactory Neuroblastoma: A 15-Year Single Institution Experience

Bijan Khademi 1 , Sima Safari 2 , Sare Hosseini 3 , * and Mohammad Mohammadianpanah 4
Authors Information
1 Department of Otolaryngology, Khalili Hospital, Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Student Research Committee, Department of Otolaryngology, and Head and Neck Surgery, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Department of Radiation Oncology, Cancer Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
4 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Reports of Radiotherapy and Oncology: September 30, 2015, 2 (3); e4472
  • Published Online: September 27, 2015
  • Article Type: Research Article
  • Received: July 11, 2015
  • Revised: August 22, 2015
  • Accepted: September 12, 2015
  • DOI: 10.17795/rro-4472

To Cite: Khademi B, Safari S, Hosseini S, Mohammadianpanah M. Olfactory Neuroblastoma: A 15-Year Single Institution Experience, Rep Radiother Oncol. 2015 ;2(3):e4472. doi: 10.17795/rro-4472.

Abstract
Copyright: Copyright © 2015, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Khademi B, Moradi A, Hoseini S, Mohammadianpanah M. Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis. Oral Maxillofac Surg. 2009; 13(4): 191-9[DOI][PubMed]
  • 2. Khademi B, Bahranifard H, Nasrollahi H, Mohammadianpanah M. [Primary mucosal melanoma of the sinonasal tract: report of 18 patients and analysis of 1077 patients in the literature]. Braz J Otorhinolaryngol. 2011; 77(1): 58-64[PubMed]
  • 3. Khademi B, Owji SM, Khosh KJ, Mohammadianpanah M, Gandomi B. Description of a neural sheath tumor of the trigeminal nerve: immunohistochemical and electron microscopy study. Sao Paulo Med J. 2006; 124(6): 333-5[PubMed]
  • 4. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol. 2001; 2(11): 683-90
  • 5. Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007; 133(3): 276-80[DOI][PubMed]
  • 6. Bak M, Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematol Oncol Clin North Am. 2012; 26(6): 1185-207[DOI][PubMed]
  • 7. Thompson LD. Olfactory neuroblastoma. Head Neck Pathol. 2009; 3(3): 252-9[DOI][PubMed]
  • 8. Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009; 16(5): 322-31[DOI][PubMed]
  • 9. Tajudeen BA, Arshi A, Suh JD, Palma-Diaz MF, Bergsneider M, Abemayor E, et al. Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013. J Neurol Surg B Skull Base. 2015; 76(1): 43-9[DOI][PubMed]
  • 10. Oskouian RJJ, Jane JAS, Dumont AS, Sheehan JM, Laurent JJ, Levine PA. Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience. Neurosurg Focus. 2002; 12(5)[PubMed]
  • 11. Theilgaard SA, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen JG, Sand Hansen H. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol. 2003; 123(3): 433-9[PubMed]
  • 12. Tsang RK, Tsang AC, Lam JW, Ho WK, Leung GK. Long-term results of endoscopic-assisted cranionasal resection for olfactory neuroblastoma - single centre experience of fourteen patients. Clin Otolaryngol. 2015; 40(3): 274-7[DOI][PubMed]
  • 13. Proust F. Treatment of esthesioneuroblastoma: a double approach? Neurochirurgie. 2015; 61(1): 54[DOI][PubMed]
  • 14. Jarzabski A, Kiprian D, Szutkowski Z, Kawecki A, Michalski W. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw]. Otolaryngol Pol. 2011; 65(5 Suppl): 93-7[DOI][PubMed]
  • 15. Modesto A, Blanchard P, Tao YG, Rives M, Janot F, Serrano E, et al. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma. Oral Oncol. 2013; 49(8): 830-4[DOI][PubMed]
  • 16. Diaz EMJ, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, et al. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center. Head Neck. 2005; 27(2): 138-49[DOI][PubMed]
  • 17. Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011; 6: 41[DOI][PubMed]
  • 18. Chao KS, Kaplan C, Simpson JR, Haughey B, Spector GJ, Sessions DG, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001; 23(9): 749-57[PubMed]
  • 19. Petruzzelli GJ, Howell JB, Pederson A, Origitano TC, Byrne RW, Munoz L, et al. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence. Am J Otolaryngol. 2015; 36(4): 547-53[DOI][PubMed]
  • 20. McLean JN, Nunley SR, Klass C, Moore C, Muller S, Johnstone PA. Combined modality therapy of esthesioneuroblastoma. Otolaryngol Head Neck Surg. 2007; 136(6): 998-1002[DOI][PubMed]
  • 21. McElroy EAJ, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. Neurosurgery. 1998; 42(5): 1023-7[PubMed]
  • 22. Porter AB, Bernold DM, Giannini C, Foote RL, Link MJ, Olsen KD, et al. Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol. 2008; 90(2): 201-4[DOI][PubMed]
  • 23. Resto VA, Eisele DW, Forastiere A, Zahurak M, Lee DJ, Westra WH. Esthesioneuroblastoma: the Johns Hopkins experience. Head Neck. 2000; 22(6): 550-8[PubMed]
  • 24. Kim HJ, Cho HJ, Kim KS, Lee HS, Kim HJ, Jung E, et al. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma. J Craniomaxillofac Surg. 2008; 36(1): 47-52[DOI][PubMed]
  • 25. Song CM, Won TB, Lee CH, Kim DY, Rhee CS. Treatment modalities and outcomes of olfactory neuroblastoma. Laryngoscope. 2012; 122(11): 2389-95[DOI][PubMed]
  • 26. Tajudeen BA, Arshi A, Suh JD, St John M, Wang MB. Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis. JAMA Otolaryngol Head Neck Surg. 2014; 140(12): 1124-9[DOI][PubMed]
  • 27. Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015; 9(1): 51-9[DOI][PubMed]
  • 28. Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys. 2007; 68(3): 758-62[DOI][PubMed]
  • 29. Rimmer J, Lund VJ, Beale T, Wei WI, Howard D. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol. Laryngoscope. 2014; 124(7): 1542-9[DOI][PubMed]
  • 30. De Bonnecaze G, Chaput B, Al Hawat A, Filleron T, Vairel B, Serrano E, et al. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma. Acta Otolaryngol. 2014; 134(12): 1259-64[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader